Analyst Research Roundup: Ceridian HCM Holding Inc. (CDAY), The Carlyle Group L.P. (CG)

Ceridian HCM Holding Inc. (NYSE:CDAY) tinted gains of +0.73% (+0.36 points) to US$49.38. The volume of 0.48 Million shares climbed down over an trading activity of 521.9 Million shares. EPS ratio determined by looking at last 12 month figures is -0.34. Over the same time span, the stock marked US$50.03 as its best level and the lowest price reached was US$28.65. The corporation has a market cap of US$6.78 Billion.

Ceridian HCM Holding Inc. (NYSE:CDAY)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -3.4 percent. The company’s institutional ownership is monitored at 81.9 percent. The company’s net profit margin has achieved the current level of -8.7 percent and possesses 43 percent gross margin.

The Carlyle Group L.P. (NASDAQ:CG) is worth US$6.14 Billion and has recently risen 0.73% to US$17.84. The latest exchange of 0.49 Million shares is below its average trading activity of 736.28 Million shares. The day began at US$17.84 but the price moved to US$17.61 at one point during the trading and finally capitulating to a session high of US$18.09. The stock tapped a 52-week high of US$25.25 while the mean 12-month price target for the shares is US$24.32.

Currently, the stock carries a price to earnings ratio of 18.62, a price to book ratio of 3.27, and a price to sales ratio of 2.53. For the past 5 years, the company’s revenue has grown -11.4%, while the company’s earnings per share has grown -6.3%. With an institutional ownership near 47.3%, it carries an earnings per share ratio of 0.96.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 5 brokerage firms polled by Factset Research. At present, 3 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 4 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.83.